已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis

弥漫性血管内凝血 医学 败血症 内科学 回顾性队列研究 重症监护医学 外科
作者
Tadashi Matsuoka,Kazuma Yamakawa,Toshiaki Iba,Koichiro Homma,Junichi Sasaki
出处
期刊:Thrombosis and Haemostasis [Georg Thieme Verlag KG]
卷期号:124 (05): 399-407 被引量:5
标识
DOI:10.1055/a-2196-3630
摘要

Background Septic-associated disseminated intravascular coagulation (DIC) is heterogeneous regarding prognosis and responsiveness to anticoagulant therapy. Objectives To investigate the relationship between the timing of development and recovery of DIC, its prognosis, and the difference in response to anticoagulant therapy in sepsis-associated DIC patients. Methods This study was performed with a dataset from a multicenter nationwide retrospective cohort study (J-Septic DIC registry) in Japan between 2011 and 2013 to reveal the subgroup “high risk of death in DIC” and investigate the relationship between anticoagulant use and mortality. Patients were assigned to four groups based on the International Society on Thrombosis and Haemostasis-overt DIC status at days 1 and 3: non-DIC (−/−), early-recovered DIC (+/−), late-onset DIC (−/+), and persistent DIC (+/+). Results A total of 1,922 patients were included. In-hospital mortality in persistent and late-onset DIC patients was significantly higher than in patients with non-DIC and early-recovered DIC. This finding indicates that persistent DIC and late-onset DIC were a poor-prognosis subgroup, “high-risk” DIC. Meanwhile, patients with high-risk DIC treated with anticoagulants had significantly better outcomes than those without anticoagulants after adjusting for confounding factors. Conclusion This study showed that individuals with a high risk of death, persistent DIC, and late-onset DIC were a poor-prognostic subgroup in septic DIC; however, high-risk DIC is also a subgroup that can obtain more benefits from anticoagulant therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张嘉雯完成签到 ,获得积分10
1秒前
1秒前
3秒前
4秒前
酷酷海豚完成签到,获得积分10
4秒前
5秒前
早睡早起发布了新的文献求助10
5秒前
隐形元绿完成签到 ,获得积分10
6秒前
遇上就这样吧应助djbj2022采纳,获得10
7秒前
喜吉尔发布了新的文献求助10
7秒前
Zziiixl完成签到,获得积分10
8秒前
bae完成签到 ,获得积分10
8秒前
月月月发布了新的文献求助10
9秒前
烟花应助美蛙鱼头头头头采纳,获得10
9秒前
longer发布了新的文献求助10
9秒前
拂晓完成签到 ,获得积分10
10秒前
10秒前
仁爱的伯云完成签到,获得积分10
11秒前
13秒前
qxy完成签到 ,获得积分10
14秒前
明亮冬萱完成签到,获得积分10
15秒前
丘比特应助yu采纳,获得10
16秒前
精明书雁发布了新的文献求助10
17秒前
绝望的文盲完成签到,获得积分10
17秒前
明亮冬萱发布了新的文献求助10
18秒前
无极微光应助百川采纳,获得20
18秒前
CYL07完成签到 ,获得积分10
19秒前
19秒前
Jason完成签到 ,获得积分10
20秒前
Bin_Liu完成签到,获得积分20
20秒前
明昼完成签到,获得积分10
23秒前
23秒前
24秒前
25秒前
王霏霏发布了新的文献求助10
25秒前
CHEN发布了新的文献求助10
27秒前
baby发布了新的文献求助10
27秒前
27秒前
28秒前
荷塘月色应助成就人杰采纳,获得10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5722957
求助须知:如何正确求助?哪些是违规求助? 5273976
关于积分的说明 15298034
捐赠科研通 4871748
什么是DOI,文献DOI怎么找? 2616169
邀请新用户注册赠送积分活动 1566020
关于科研通互助平台的介绍 1522944